VIMPAT (lacosamide) injection for intravenous use is indicated as adjunctive therapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older when oral...
Vimpat: Uses, Dosage, Side Effects, Warnings - Drugs.com
2023年12月6日 · Vimpat is used to treat partial onset seizures and primary generalized tonic-clonic seizures in adults and children with epilepsy who are at least 4 years old. Learn about side effects, interactions and indications.
Vimpat, Motpoly XR (lacosamide) dosing, indications, interactions ...
Indicated as adjunctive therapy for primary generalized tonic-clonic seizures. IV administration indicated as short-term replacement (up to 5 consecutive days) when PO administration is not...
Lacosamide Dosage Guide + Max Dose, Adjustments - Drugs.com
2023年12月19日 · Administer as IV infusion preferably over 30 to 60 minutes; if necessary, may infuse over 15 minutes in adults.
Vimpat Dosage Guide - Drugs.com
2024年9月23日 · VIMPAT injection can be administered intravenously to adult and pediatric patients weighing 6 kg or more with the same dosing regimens described for oral dosing. For pediatric patients weighing less than 6 kg, VIMPAT injection may be initiated with a dose of 0.66 mg/kg three times daily (see Table 1 ).
UCB’s VIMPAT [®] (lacosamide) CV now approved by FDA in U.S.
2020年11月17日 · VIMPAT is available in three formulations: oral tablets, oral solution, and intravenous (IV) injection. VIMPAT® is indicated for the treatment of partial-onset seizures in patients 4 years of age and older. VIMPAT is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.
Dosage IV lacosamide is FDA-labeled as adjunctive therapy for partial-onset seizures in patients with epilepsy who are 17 years and older when oral administration is temporarily not feasible.
Vimpat can only be obtained with a prescription and is available as tablets, as a syrup and as a solution for infusion (dr ip) into a vein. Vimpat should be taken twice a day; the dosage depends on the patient’s weight and age, as well as whether …
VIMPAT (lacosamide) injection for intravenous use is indicated as adjunctive therapy in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older when oral...
Lacosamide - Epilepsy Foundation
2024年3月15日 · Lacosamide (la-COS-a-mide) is the generic name (non-brand name) for the brand drug called Vimpat (VIM-pat) from UCB. It is available in tablet form, a liquid solution, and a liquid for injection. Lacosamide is available in many …